The prevalence of cystoid macular oedema on optical coherence tomography in retinitis pigmentosa patients without cystic changes on fundus examination

被引:42
作者
Hajali, M. [1 ]
Fishman, G. A. [1 ]
机构
[1] Univ Illinois, Dept Ophthalmol & Visual Sci, Eye & Ear Infirm, Chicago, IL 60612 USA
关键词
retinitis pigmentosa; macular oedema; OCT; INTRAVITREAL TRIAMCINOLONE; ANTIRETINAL ANTIBODIES; RETINAL THICKNESS; ACETAZOLAMIDE; ASSOCIATION; BREAKDOWN; LESIONS;
D O I
10.1038/eye.2008.110
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose To determine the prevalence of cystoid macular oedema (CME) by optical coherence tomography (OCT) in retinitis pigmentosa (RP) patients with no evidence of cystic macular lesions on fundus examination. Methods We included 63 RP patients with no evidence of cystic-appearing macular changes on fundus examination. All patients underwent a complete ocular examination including best-corrected visual acuity using an ETDRS (Early Treatment Diabetic Retinopathy Study) chart, intraocular pressure measurement, anterior segment examination, and a detailed fundus examination. On 50 of the 63 patients, Fourier-domain OCT was performed using the radial slicer protocol. An additional 13 of the 63 patients were scanned using the macular thickness protocol on a time-domain OCT unit. The diagnosis of CME was defined by the presence of hyporeflective lacunae with well-defined boundaries on at least two of the scans. Results The mean age of patients included in the study was 36 years (range 9-71 years). Out of the 63 patients examined, 20 showed CME in at least one eye (32%), whereas 11 patients showed CME in both eyes (18%). Conclusions Our findings demonstrate that a substantial number of RP patients with CME, as determined by OCT, may not show cystic changes by direct ophthalmoscopy or contact lens biomicroscopy. Knowledge of the high frequency for CME in such patients can serve to identify those who may be amenable to current or future treatment strategies of their macular oedema and can potentially impact on future therapeutic trials where visual acuity is used as an outcome measure. CLINICAL STUDY
引用
收藏
页码:915 / 919
页数:5
相关论文
共 29 条
[1]   Prevalence of cystoid macular edema and stability in OCT retinal thickness in eyes with retinitis pigmentosa during a 48-week lutein trial [J].
Adackapara, Cheryl A. ;
Sunness, Janet S. ;
Dibernardo, Cathy W. ;
Melia, B. Michele ;
Dagnelie, Gislin .
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2008, 28 (01) :103-110
[2]  
BERSON EL, 1993, INVEST OPHTH VIS SCI, V34, P1659
[3]   Characterization of macular edema from various etiologies by optical coherence tomography [J].
Catier, A ;
Tadayoni, R ;
Paques, M ;
Erginay, A ;
Haouchine, B ;
Gaudric, A ;
Massin, P .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2005, 140 (02) :200-206
[4]   Optical coherence tomography in the diagnosis and monitoring of cystoid macular edema in patients with retinitis pigmentosa [J].
Chung, Hyewon ;
Hwang, Jong-Uk ;
Kim, June-Gone ;
Yoon, Young Hee .
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2006, 26 (08) :922-927
[5]  
COX SN, 1988, ARCH OPHTHALMOL-CHIC, V106, P1190
[6]   BREAKDOWN OF THE BLOOD-RETINAL BARRIERS AND CYSTOID MACULAR EDEMA [J].
CUNHAVAZ, JG ;
TRAVASSOS, A .
SURVEY OF OPHTHALMOLOGY, 1984, 28 :485-492
[7]  
FETKENHOUR CL, 1977, T AM ACAD OPHTHALMOL, V83, P515
[8]  
FISHMAN GA, 1977, ARCH OPHTHALMOL-CHIC, V95, P798
[9]  
FISHMAN GA, 1994, OPHTHALMOLOGY, V101, P687
[10]  
FISHMAN GA, 1988, ARCH OPHTHALMOL-CHIC, V106, P369